DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executi...( MISSISSAUGA ON Oct. 31 / DRAXIS H...),Health

MISSISSAUGA, ON, Oct. 31 /PRNewswire-FirstCall/ - DRAXIS Health Inc. (TSX: DAX) (Nasdaq: DRAX) announces that Dr. Martin Barkin today informed the board of directors that he will retire as the President and Chief Executive Officer of the Company effective December 31, 2007.

Dr. Barkin joined the senior management of DRAXIS in 1992. Over the last fifteen years, he has been instrumental in guiding the Company through a period of significant growth from a small Canadian pharmaceutical marketing company to its current position as a provider of specialized pharmaceutical and radiopharmaceutical products in markets globally.

Brian King, Chair of the board of directors, indicated that, "The Board of Directors wishes to acknowledge and thank Martin for the significant contribution that he has made to the growth and strategic positioning of DRAXIS during his time at the Company and for his dedication to its employees, its goals and its progress over the years. The Board of Directors has commenced a process to identify Dr. Barkin's successor."

With Dr. Barkin's impending retirement, Dan Brazier, presently Chief Operating Officer, will immediately take on the roles and responsibilities currently held by Dr. Barkin until a successor is appointed as President and Chief Executive Officer.

Dr. Barkin said, "I have worked closely together with Dan Brazier for the last several months in the Office of the President and he has been assuming more and more of my responsibilities. I have become very comfortable with his abilities and, therefore, the time was now right for me to inform the board of my intentions to retire at the end of this year."

About DRAXIS Health Inc.:

DRAXIS Health, through its wholl
'/>"/>